ClinicalTrials.govpublic full text
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
coronary artery disease, coronary disease, cardiovascular diseases, rosuvastatin calcium, percutaneous coronary intervention, drug-eluting stents, patient outcome assessment, biomarkers, hyperlipidemias, dyslipidemias, atherosclerosis, hydroxymethylglutaryl-coa reductase inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 848066
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.